Green Angel Ventures today announced it has completed a new investment in Deakin Bio-Hybrid Materials Limited.
Deakin Bio’s technology creates composites by combining bio-derived binders with widely available waste minerals, such as crushed limestone.
Initial applications are to provide alternatives to decorative ceramic tiles, helping to address the industry’s significant challenges with high energy prices and tighter emission regulations. Deakin Bio’s solution has a carbon footprint 94 per cent lower than conventional tiles made on the same equipment and creates products with more than 95 per cent recycled content.
The fundraising was led by Green Angel Ventures, which is the UK’s leading specialist in early stage climate related technology innovation investments. Its Syndicate provides the best access to added value that an investor can offer an early stage or start-up company in this field.
Deakin Bio was founded by Chief Executive Officer Dr Aled Roberts, who holds a PhD in Materials Chemistry from the University of Liverpool.
Dr Aled Roberts, DeakinBio CEO, said: “We are excited to complete the investment round with Green Angel Ventures. The money will allow us to scale up production with a tile manufacturer and begin commercial sales.”
Cam Ross, CEO of Green Angel Ventures, said: “We are delighted to complete this investment in DeakinBio. The commitment of our syndicate to ground-breaking innovations in carbon reducing technologies is exemplified in the process being introduced by DeakinBio. It manages to recalibrate the entire production model into a circular system while also cutting carbon emissions.”
